Keep me
updated
06 March 2009
Notification of Interest
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, was notified on 6 March 2009 that, following the purchase of shares in the Company on the same day, P Mahon holds 2,083,302 ordinary shares in Futura, representing 3.3% of the issued share capital of the Company.
For further information please contact:
Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670
james.barder@futuramedical.com
www.futuramedical.com
Nominated Adviser:
Nomura Code Securities Limited
Phil Walker / Giles Balleny
Tel: +44 (0) 20 7776 1200
For media enquiries please contact:
Buchanan Communications Limited
Mark Court / Jessica Fontaine
Tel: +44 (0) 20 7466 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.